Vyome director granted 120K options at $2.17

Vyome Holdings director Mohanjit Jolly received a fully vested grant of 120,000 stock options at a $2.17 exercise price expiring in 2036.

Rhea-AI Filing Summary

Vyome Holdings, Inc (HIND) reported that director Mohanjit Jolly received a grant of stock options on September 1, 2026. The grant covers 120,000 options to purchase Vyome common stock at an exercise price of $2.17 per share under the company’s 2025 Equity Incentive Plan. The options are fully vested and expire on September 1, 2036, bringing Jolly’s directly held derivative position to 137,833 options after the grant. No Rule 10b5-1 trading plan is reported for this award.

Insider Trade Summary

Grant/Award: 120,000 shares

Grant/Award 1 txn

Insider Jolly Mohanjit

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	120,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 137,833 contracts (Direct)

Footnotes (1)

1. F1. On September 1, 2026 the reporting person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's 2025 Equity Incentive Plan. The shares subject to the option are fully vested.

Key Figures

Options granted: 120,000 options Exercise price: $2.17 per share Expiration date: September 1, 2036 +3 more

6 metrics

Options granted 120,000 options Stock option grant to director Mohanjit Jolly on September 1, 2026

Exercise price $2.17 per share Conversion or exercise price of the granted stock options

Expiration date September 1, 2036 Expiration of the 120,000 granted stock options

Post-grant derivative holdings 137,833 options Total stock options held directly by Mohanjit Jolly after the transaction

Vested options in grant 120,000 options All shares subject to the September 1, 2026 option grant are fully vested

Rule 10b5-1 plan status No plan reported Affirmative 10b5-1 checkbox is not marked for this Form 4

Key Terms

Stock Option (right to buy), 2025 Equity Incentive Plan, exercise price, expiration date

4 terms

Stock Option (right to buy) financial

"Reports a security titled Stock Option (right to buy) as the derivative"

2025 Equity Incentive Plan financial

"Granted pursuant to the Issuer's 2025 Equity Incentive Plan"

exercise price financial

"Shows a conversion or exercise price of 2.1700 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"Lists an expiration date of 2036-09-01 for the option"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vyome Holdings (HIND) report for Mohanjit Jolly?

Vyome Holdings reported that director Mohanjit Jolly received a grant of 120,000 stock options on September 1, 2026. The options allow him to purchase Vyome common stock at an exercise price of $2.17 per share and are fully vested at grant.

What is the exercise price and term of the new Vyome (HIND) stock options?

The granted stock options have an exercise price of $2.17 per share and an expiration date of September 1, 2036. They were issued under Vyome’s 2025 Equity Incentive Plan and are fully vested as of the grant date.

How many Vyome (HIND) derivative securities does Mohanjit Jolly hold after this Form 4?

Following the reported grant, Mohanjit Jolly holds 137,833 stock options directly. The reported transaction reflects an acquisition of 120,000 new options, increasing his derivative holdings to this post-transaction amount.

Are the new Vyome (HIND) stock options for Mohanjit Jolly vested?

Yes. The footnote states that the option to purchase 120,000 shares of Vyome common stock is fully vested as of the grant on September 1, 2026, meaning all 120,000 underlying shares are immediately exercisable under the plan terms.

Was the Vyome (HIND) option grant to Mohanjit Jolly made under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and the footnote does not reference any such trading plan. The reported transaction is a compensation-related option grant under the 2025 Equity Incentive Plan, not a sale or purchase under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:51 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jolly Mohanjit

(Last) (First) (Middle)

HARVARD SQUARE

ONE MIFFLIN PLACE, SUITE 400

(Street)

CAMBRIDGE MASSACHUSETTS 02138

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vyome Holdings, Inc [ HIND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)(1)	$2.17	09/01/2026		A(1)		120,000		(1)	09/01/2036	Common Stock	120,000	$0	137,833	D

Explanation of Responses:

1. On September 1, 2026 the reporting person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's 2025 Equity Incentive Plan. The shares subject to the option are fully vested.

	/s/ Mohanjit Jolly	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)